|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02361 SINOHEALTH TECH
Nominal 
5.100 -0.080 (-1.544%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 403,728 | 396,194 | 356,668 | 324,166 |
| Cost of Sales | -- | -- | (170,527) | (172,722) | (197,560) | (131,527) |
| Gross Profit | -- | -- | 233,201 | 223,472 | 159,108 | 192,639 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (12,861) | (24,079) | (2,678) | (2,855) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | 0 | 0 | 0 | (416) | |
| Profit / (Loss) before Taxation | -- | -- | 120,148 | 110,741 | 54,474 | 95,529 | |
| Taxation | -- | -- | (8,325) | (9,801) | (261) | (23,551) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | (1,174) | 1,092 | 1,545 | 6,835 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 93,437 | -15.555% | 110,649 | 102,032 | 55,758 | 78,813 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | (25,671) | (26,028) | (6,203) | 284 |
| Depreciation & Amortisation | -- | -- | 8,044 | 8,566 | 8,729 | 7,352 |
| Directors' Emoluments | -- | -- | 3,826 | 2,306 | 1,981 | 1,376 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 20.680 | -23.322% | 26.970 | 23.940 | 13.580 | 21.120 |
| DPS (cts) | 6.267 | -- | 19.986 | 6.574 | 3.493 | -- |
| Dividend Payout Ratio (%) | 30.303% | -- | 74.103% | 27.461% | 25.720% | -- |
| Cash flow per share ($) | -- | -- | 0.224 | 0.186 | 0.079 | 0.161 |
| NBV per share ($) | -- | -- | 1.573 | 1.557 | 1.538 | -- |
| Remarks: | Real time quote last updated: 30/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 93,437 |
| %Change | -15.555% |
| EPS / (LPS) | RMB 0.207 |
| NBV Per Share (¥) | RMB -- |